Tradeline, Inc. filters and categorizes new-construction and industry news from regional and professional journals across the country. Here you will find new projects, products, and regulatory updates.
Industry News
Ethiopian Biosafety Lab Opens in Sebeta
Ethiopia's Ministry of Agriculture and Rural Development opened a $90,000 biosafety laboratory in Sebeta in May of 2009. The BSL-3 facility will be operated by the National Animal Health Diagnostic and Investigation Centre. Enabling the diagnosis of zoonotic and infectious diseases, the facility includes biosafety cabinets, a refrigerated micro-centrifuge, incubators, a thermo-mixer, and a PCR work station.
Indonesia Plans Flu Vaccine Labs
Indonesia’s Ministry of Health announced plans in May of 2009 to build a flu vaccine research and production facility. The laboratory will eventually manufacture a single human vaccine for swine and avian flu viruses. A flu vaccine laboratory is currently under construction at Airlangga University in Surabaya, East Java. Construction began on a flu vaccine facility at the PT Biofarma campus in Bandung in May of 2009.
Aeras Opens Vaccine Manufacturing Plant
The Aeras Global TB Vaccine Foundation opened its 9,000-sf vaccine manufacturing facility in Rockville, Md., in April of 2009. The project will support tuberculosis vaccine development and production, as well as research into aerosol vaccine formulations. The BSL-2 facility was built by general contractor Whiting-Turner of Baltimore.
NIAID's Integrated Research Facility Nears Completion
The National Institute of Allergy and Infectious Diseases is building the $105 million Integrated Research Facility (IRF) in Fort Detrick, Md. Housing BSL-2, BSL-3, and BSL-4 laboratories for select agent and infectious disease research, the IRF will provide 11,125-sf of secure research space for 30 investigators. The building will feature PET, CT, MRI, and X-ray scanners to study the effects of infectious diseases on primates. The construction manager for the project is Gilbane Building Company.
NanoLogix Builds Production Facility
NanoLogix began construction on a manufacturing facility for bacteria and pathogen test kits in April of 2009. Located at NanoLogix’s headquarters in Hubbard, Ohio, the 2,800-sf project will include a production cleanroom and a cold storage vault. The BNP™ Ultra-Fast test kits will be used to detect agents such as anthrax, bubonic plague, e-coli, salmonella, listeria, and enterobacter.